II. Indications
- 
                          Acute Migraine Headache
                          - Third-line agent in Acute Migraine Headaches refractory to NSAIDS and Triptans
- Avoid for acute Migraines if also using Injectable CGRP Inhibitor for Migraine Prophylaxis
- Avoid using in combination with Triptans (no evidence of benefit)
 
- 
                          Migraine Prophylaxis
                          - Rimegepant (Nurtec) is FDA approved for Migraine Prophylaxis in 2021 (third-line agent)
- Injectable CGRP Inhibitors are also indicated in Migraine Prophylaxis
 
III. Mechanism
- 
                          Calcitonin
                          Gene-Related Peptide (CGRP)- CGRP is a neuropeptide that acts as a vasodilator and pain sensitization
- CGRP Is released by trigeminal Neurons in Migraine Headache, Cluster Headache and Trigeminal Neuralgia
 
- CGRP Inhibitors block CalcitoninGene-Related Peptide (CGRP)- Gepants are oral or intranasal agents that block CGRP
- Contrast with CGRP Monoclonal Antibody agents that are injectable
 
IV. Preparations
- Ubrogepant (Ubrelvy)- Dose: 50 to 100 mg orally with or without food- May repeat a second dose 2 hours after first)
- Maximum: 200 mg/24 hours
 
- Costs $85 per tablet (contrast with 70 cents per Sumatriptan tablet)
- May be repeated 2 hours after first dose if inadequate effect
- Resources: DailyMed
 
- Dose: 50 to 100 mg orally with or without food
- Rimegepant (Nurtec)- Migraine Abortive Treatment- Dissolving oral tablet: 75 mg taken as single dose (maximum 75 mg/day)
 
- Migraine Prophylaxis- Dissolving oral tablet: 75 mg taken every OTHER day (maximum 18 days per month)
- Breakthrough Acute Migraine Headache should not be treated with Rimegepant- Use another type of Migraine Abortive Treatment
 
- Cost: $1800/month (contrast with $630/month for Injectable CGRP Inhibitors)
 
- Resources: DailyMed
 
- Migraine Abortive Treatment
- Zavegepant (Zavzpret)- Intranasal Gepant (useful when Nausea, Vomiting interferes with taking medication)
- Migraine Abortive Treatment Dosing- One spray (10 mg/spray) intranasal per 24 hours as needed
 
- Pharmacokinetics- Onset: 15 minutes
- Peak: 30 minutes
- Half-Life: 6.5 hours
 
- Adverse Effects
- Safety- Has not been studied in pregnancy, children, liver or renal Impairment
 
- References
 
- Atogepant (Qulipta)- Migraine Prophylaxis- Start 10 mg orally daily (maximum dose 60 mg/day)
- Adjust dose for CYP3A4 inhibitors and inducers, as well as OATP Inhibitors
 
- Resources: DailyMed
 
- Migraine Prophylaxis
V. Efficacy
- 
                          Migraine Abortive Treatment (less effective than Triptans)- NNT 10 for one patient to be pain free at 2 hours
- Contrast with the more effective and less expensive Triptans- Sumatriptan NNT 5
- Cost of Gepants (>$100/dose) in 2024 is as much as 100 fold more than Triptans
 
 
- 
                          Migraine Prophylaxis
                          - Rimegepant prevents 1 Migraine more than Placebo per month in those with 10 Migraines/month on average
- Similar efficacy to other Migraine Prophylaxis agents including Injectable CGRP Inhibitors
 
VI. Adverse Effects
VII. Drug Interactions
VIII. References
- (2024) Presc Lett 31(2): 9-10
- (2020) Presc Lett 27(3): 13
- (2021) Presc Lett 28(8): 43-4
- LoVecchio (2020) Crit Dec Emerg Med 34(2):28
- LoVecchio (2023) Crit Dec Emerg Med 37(5):32
Images: Related links to external sites (from Bing)
Related Studies
| ubrelvy (on 1/14/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| UBRELVY 100 MG TABLET | $90.07 each | |
| UBRELVY 50 MG TABLET | $89.78 each | |
| nurtec (on 1/17/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| NURTEC ODT 75 MG TABLET | $110.19 each | |
| zavzpret (on 10/18/2023 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| ZAVZPRET 10 MG NASAL SPRAY | $175.94 each | |
| qulipta (on 2/23/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| QULIPTA 10 MG TABLET | $31.82 each | |
| QULIPTA 30 MG TABLET | $31.52 each | |
| QULIPTA 60 MG TABLET | $31.83 each | |
